Sanofi’s Kadmon Bolt-On Bolsters Its General Medicine Division

Deal Adds Transplant Pill Rezurock For Chronic Graft-Versus-Host Disease

Sanofi Is Paying $1.9bn cash for US Biotech • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business